INMED PHARMACEUTICALS INC. Income Taxes Paid
INMED PHARMACEUTICALS INC. (INM) reported Income Taxes Paid of $0 for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. income taxes paid for the quarter ending 2026-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. income taxes paid for the quarter ending 2025-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. income taxes paid for fiscal 2023 was $13.10K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $0.00 S-4/A · filed 2026-09-09 | ||
| 2026-03-31 | $0.00 S-4 · filed 2026-07-02 | |||
| 2025-06-30 | $0.00 derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $0.00 S-4/A · filed 2026-09-09 | ||
| 2025-03-31 | $0.00 S-4 · filed 2026-07-02 | |||
| 2024-06-30 | $7.10K S-4 · filed 2026-07-02 | |||
| 2023-06-30 | $13.10K 10-K · filed 2024-09-30 | |||
| 2022-12-31 | $9.80K 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |